Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report) was the target of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 182,100 shares, a decrease of 20.1% from the August 31st total of 227,800 shares. Based on an average daily volume of 2,000,000 shares, the days-to-cover ratio is currently 0.1 days.
Analysts Set New Price Targets
Several analysts have recently issued reports on the stock. HC Wainwright reduced their price target on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, June 24th. StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Saturday, September 21st. They set a “sell” rating on the stock.
Read Our Latest Analysis on AEMD
Aethlon Medical Stock Performance
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last released its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter in the previous year, the business earned ($1.30) EPS. Equities analysts forecast that Aethlon Medical will post -1.1 EPS for the current fiscal year.
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Featured Stories
- Five stocks we like better than Aethlon Medical
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- How to Evaluate a Stock Before BuyingÂ
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Insider Selling Explained: Can it Inform Your Investing Choices?
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.